НовостиBenzingaDogwood Therapeutics Enters Into Securities Subscription Agreement For $5 Investment From CK Life Sciences’ Subsidiary Dogwood Therapeutics Enters Into Securities Subscription Agreement For $5 Investment From CK Life Sciences’ Subsidiary Benzinga 2026.10.19 12:35 (GMT+0) Открыть на Benzinga Другие новости